XML 134 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net loss $ (34,969) $ (50,027) $ (72,788)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation and amortization 79,839 71,575 73,986
Amortization of deferred financing costs and original issue discount 3,666 3,333 3,046
Loss on asset disposals 3,397 390 70
Share-based compensation 3,445 3,017 3,021
Other adjustments (5) 1,690 2,425
Changes in assets and liabilities:      
Accounts receivable 936 (6,698) 4,087
Inventories 9,914 (8,670) 59
Prepaid expenses and other current assets 1,582 (1,196) 1,052
Accounts payable (8,077) 5,215 (2,315)
Deferred revenue (14,575) 10,828 904
Accrued expenses and other current liabilities (6,542) 1,367 (4,969)
Other long-term assets and liabilities 546 1,410 1,822
Net cash provided by operating activities 39,157 32,234 10,400
Cash flows from investing activities:      
Capital expenditures (18,656) (19,806) (14,556)
Proceeds from the sale of assets 127 175 0
Net cash used in investing activities (18,529) (19,631) (14,556)
Cash flows from financing activities:      
Cash distributions to common unitholders – Affiliates (15,568) 0 (778)
Cash distribution to common unitholders – Non-affiliates (29,745) 0 (1,488)
Other financing activities (97) 0 0
Net cash used in financing activities (45,410) 0 (2,266)
Net (decrease) increase in cash and cash equivalents (24,782) 12,603 (6,422)
Cash and cash equivalents, beginning of period 61,776 49,173 55,595
Cash and cash equivalents, end of period $ 36,994 $ 61,776 $ 49,173